Herbas VPB

Print
EN | LT
LT - CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CYSTITIS
EN - CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CYSTITIS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 38/17
C07K 14/47
A61K 48/00
C07K 16/40
C12N 15/00
A61P 25/28
A61P 3/10
A61P 41/00
A61P 13/12
A61K 38/55
A61P 1/00
A61P 1/02
A61P 1/04
A61P 1/16
A61P 1/18
A61P 3/00
A61P 3/08
A61P 5/00
European patent
(11) Number of the document 3013353
(13) Kind of document T
(96) European patent application number 14734003.8
Date of filing the European patent application 2014-06-26
(97) Date of publication of the European application 2016-05-04
(45) Date of publication and mention of the grant of the patent 2021-04-21
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/EP2014/001736
Date 2014-06-26
PCT application publication
(87) Number WO 2014/206563
Date 2014-12-31
Priority applications
(30) Number Date Country code
PCT/EP2013/0018 2013-06-26 WO
PCT/EP2013/0018 2013-06-27 WO
Inventors
(72)
COMBETTE, Jean-Marc, FR
DELOCHE, Catherine, CH
Grantee
(73) Xigen Inflammation Ltd., Arch. Makariou III 195 Neocleous House, 3030 Limassol, CY
Title
(54) CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CYSTITIS
  CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CYSTITIS